Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-2018 | 11-2017 | 08-2017 | 05-2017 | 02-2017 | |
| Sales | 604 | 611 | 0 | 617 | 611 |
| Gross Profit | 604 | 611 | N/A | 617 | 611 |
| Operating Expenses | 3,715 | 3,343 | 0 | 2,772 | 3,976 |
| Operating Income | -3,111 | -2,732 | N/A | -2,155 | -3,365 |
| Interest Expense | 22 | 21 | 0 | 20 | 21 |
| Other Income | 217 | 222 | 0 | 210 | 203 |
| Pre-tax Income | -2,916 | -2,531 | 0 | -1,965 | -3,183 |
| Net Income Continuous | -2,916 | -2,531 | N/A | -1,965 | -3,183 |
| Net Income | $-2,916 | $-2,531 | $N/A | $-1,965 | $-3,183 |
| EPS Basic Total Ops | -0.20 | -0.18 | N/A | -0.15 | -0.24 |
| EPS Basic Continuous Ops | -0.20 | -0.18 | N/A | -0.15 | -0.24 |
| EPS Diluted Total Ops | -0.20 | -0.18 | N/A | -0.15 | -0.24 |
| EPS Diluted Continuous Ops | -0.20 | -0.18 | N/A | -0.15 | -0.24 |
| EBITDA(a) | $-3,108 | $-2,731 | $N/A | $-2,152 | $-3,364 |